ConductScience.org, home

Paper40700321

Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.

Garduño-Orbe B and 7 others. Infect Dis Rep, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic. Papers, record 40700321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40700321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.
PubMed
Journal
Infect Dis Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-07-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garduño-Orbe BBrenda
2Palma-Ramírez PSPaola Selene
3López-Ortiz EEduardo
4García-Morales GGabriela
5Sánchez-Rebolledo JMJuan Manuel
6Emigdio-Loeza AAlexis
7Gómez-García AAnelhttps://orcid.org/0000-0002-9158-1095
8López-Ortiz GGeovanihttps://orcid.org/0000-0003-0280-0012

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139708059Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States.Infect Dis Ther2025https://conductscience.org/library/papers/39708059PubMed
238505296Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods.Open Forum Infect Dis2024https://conductscience.org/library/papers/38505296PubMed
332320003Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.JAMA2020https://conductscience.org/library/papers/32320003PubMed
434035524Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.Nat Metab2021https://conductscience.org/library/papers/34035524PubMed
533479118Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.Science2021https://conductscience.org/library/papers/33479118PubMed
635513438Beyond comorbidities, sex and age have no effect on COVID-19 health care demand.Sci Rep2022https://conductscience.org/library/papers/35513438PubMed
735717236Barriers to COVID-19 vaccination among older adults in Mexico City.Int J Equity Health2022https://conductscience.org/library/papers/35717236PubMed
836879082Functional outcomes in post Covid-19 patients with persistent dyspnea: multidisciplinary approach.Int J Cardiovasc Imaging2023https://conductscience.org/library/papers/36879082PubMed
940014628Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.MMWR Morb Mortal Wkly Rep2025https://conductscience.org/library/papers/40014628PubMed
1032967006SARS-CoV-2 vaccines in development.Nature2020https://conductscience.org/library/papers/32967006PubMed
1135099875Acceptance, refusal and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19.Salud Publica Mex2021https://conductscience.org/library/papers/35099875PubMed
1234320281Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.N Engl J Med2021https://conductscience.org/library/papers/34320281PubMed
1333692570COVID-19 and liver disease: mechanistic and clinical perspectives.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33692570PubMed
1433301246Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.N Engl J Med2020https://conductscience.org/library/papers/33301246PubMed
1534461056Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis2022https://conductscience.org/library/papers/34461056PubMed
1637080227COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint.Lancet Respir Med2023https://conductscience.org/library/papers/37080227PubMed
1717167474Inflammation and metabolic disorders.Nature2006https://conductscience.org/library/papers/17167474PubMed
1834192737Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.Nature2021https://conductscience.org/library/papers/34192737PubMed
1933444545SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.Lancet Gastroenterol Hepatol2021https://conductscience.org/library/papers/33444545PubMed
2033306989Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet2021https://conductscience.org/library/papers/33306989PubMed

See all 46 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41773107The Impact of Disease-Modifying Antirheumatic Drugs on In-Hospital Outcomes of Patients With COVID-19: A Retrospective Cohort Study and Literature Review.Cureus2026https://conductscience.org/library/papers/41773107PubMed
41441721Socioeconomic Barriers to COVID-19 Booster Vaccination in Southern Italy: A Retrospective Study to Evaluate Association with the Social and Material Vulnerability Index in Apulia.Vaccines (Basel)2025https://conductscience.org/library/papers/41441721PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40700321

GET https://conductscience.org/api/papers/v1/40700321/references?page=2